Scarlet Begonias Biotech

Scarlet Begonias Biotech appears to have been a planned biotech venture associated with Blue Sun Mycology Group rather than a clearly established standalone operating company. Publicly available evidence indicates it was intended to work on psychoactive fungi and related novel bioactive organisms using proprietary breeding, hybridization, and compound-development methods. The limited disclosures suggest a focus on creating new psilocybin-related fungal products and other unconventional psychedelic biological products for the emerging psychedelic market. However, there is no strong evidence of a mature corporate footprint, clinical pipeline, financing history, or sustained operations under this exact name. Based on available information, it is best characterized as an early, preclinical psychedelic biotech concept or planned entity with very limited verifiable independent company data.